These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7893365)

  • 1. The p53 and mdm-2 genes in human testicular germ-cell tumors.
    Riou G; Barrois M; Prost S; Terrier MJ; Theodore C; Levine AJ
    Mol Carcinog; 1995 Mar; 12(3):124-31. PubMed ID: 7893365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
    Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
    Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the p53 and MDM-2 gene in acute myeloid leukemia.
    Seliger B; Papadileris S; Vogel D; Hess G; Brendel C; Störkel S; Ortel J; Kolbe K; Huber C; Huhn D; Neubauer A
    Eur J Haematol; 1996 Sep; 57(3):230-40. PubMed ID: 8898928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression.
    Datta MW; Macri E; Signoretti S; Renshaw AA; Loda M
    Mod Pathol; 2001 May; 14(5):437-42. PubMed ID: 11353054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors.
    Schenkman NS; Sesterhenn IA; Washington L; Tong YA; Weghorst CM; Buzard GS; Srivastava S; Moul JW
    J Urol; 1995 Aug; 154(2 Pt 1):617-21. PubMed ID: 7609148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
    Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the p53 gene are not detectable in human testicular tumors.
    Fleischhacker M; Strohmeyer T; Imai Y; Slamon DJ; Koeffler HP
    Mod Pathol; 1994 May; 7(4):435-9. PubMed ID: 8066072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutation without allelic loss and absence of mdm-2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters.
    Okita S; Tsutsumi M; Onji M; Konishi Y
    Mol Carcinog; 1995 Aug; 13(4):266-71. PubMed ID: 7646765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.
    Kuczyk MA; Serth J; Bokemeyer C; Jonassen J; Machtens S; Werner M; Jonas U
    Cancer; 1996 Nov; 78(9):1958-66. PubMed ID: 8909317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma.
    Gorgoulis VG; Rassidakis GZ; Karameris AM; Papastamatiou H; Trigidou R; Veslemes M; Rassidakis AN; Kittas C
    Mod Pathol; 1996 May; 9(5):544-54. PubMed ID: 8733770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines.
    Taylor AC; Shu L; Danks MK; Poquette CA; Shetty S; Thayer MJ; Houghton PJ; Harris LC
    Med Pediatr Oncol; 2000 Aug; 35(2):96-103. PubMed ID: 10918230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mdm-2 expression in human testicular germ-cell tumors and its clinical value.
    Eid H; Institoris E; Géczi L; Bodrogi I; Bak M
    Anticancer Res; 1999; 19(4C):3485-90. PubMed ID: 10629640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human MDM-2 oncogene is overexpressed in leukemias.
    Bueso-Ramos CE; Yang Y; deLeon E; McCown P; Stass SA; Albitar M
    Blood; 1993 Nov; 82(9):2617-23. PubMed ID: 8219216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations and MDM-2 amplification in renal cell cancers.
    Imai Y; Strohmeyer TG; Fleischhacker M; Slamon DJ; Koeffler HP
    Mod Pathol; 1994 Sep; 7(7):766-70. PubMed ID: 7824511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation.
    Pruneri G; Pignataro L; Carboni N; Luminari S; Capaccio P; Neri A; Buffa R
    Mod Pathol; 1997 Aug; 10(8):785-92. PubMed ID: 9267820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression.
    Poremba C; Yandell DW; Metze D; Kamanabrou D; Böcker W; Dockhorn-Dworniczak B
    Oncol Res; 1995; 7(7-8):331-9. PubMed ID: 8747596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines.
    Cheng YT; Li YL; Wu JD; Long SB; Tzai TS; Tzeng CC; Lai MD
    Mol Carcinog; 1995 Jul; 13(3):173-81. PubMed ID: 7619220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of P53 and MDM2 in treatment response of human germ cell tumors.
    Kersemaekers AM; Mayer F; Molier M; van Weeren PC; Oosterhuis JW; Bokemeyer C; Looijenga LH
    J Clin Oncol; 2002 Mar; 20(6):1551-61. PubMed ID: 11896104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J; Lin J; Levine AJ
    Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.